ESR1 and breast cancer: Moreover, seven in absentia homolog 2 inhibits LATS2 to stimulate YAP [322], and LATS1/2 maintains estrogen receptor alpha (Erα) expression by inhibiting YAP/TAZ, thereby promoting the growth of ERα+ breast cancer cells.